Isabella Ciccone is an Assistant Editor at NeurologyLive, specializing in neurology and healthcare topics. With a background in healthcare journalism, Isabella's work has appeared in various publications such as AJMC, Managed Healthcare Executive, and Pharmaceutical Executive. She is dedicated to providing accurate and informative content in the field of neurology.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Not enough data
Isabella's coverage primarily focuses on neurology and healthcare & pharmaceutical topics, with an emphasis on citing data to support her articles. She may be interested in receiving pitches from experts who can provide insights into the latest research findings, clinical trials, or scientific developments within these areas.
Given the technical nature of Isabella's articles and her reliance on data, she is likely to respond well to pitches that offer expert commentary backed by credible research or statistical evidence. Pitches should demonstrate a clear understanding of the specific medical conditions and treatments discussed in her articles.
Since Isabella does not have a specified geographic focus, she appears open to covering international developments in neurology and healthcare without restriction to a particular region.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Marco Meglio, Jacqueline A. French, Isabella Ciccone
The professor of neurology at NYU Grossman School of Medicine discussed a pioneering study using long seizure episodes to optimize treatment devices and identify effective antiseizure drugs in epilepsy care. [WATCH TIME: 2 minutes]
By: Isabella Ciccone, Jessica Nickrand, Allyson Eyermann
A duo from Child Neurology Foundation discussed advancing care, providing education for all stakeholders, and offering direct support to families, clinicians, and caregivers navigating neurological conditions for pediatric patients. [WATCH TIME: 5 minutes]
By: Laura Kirkpatrick, Adam Numis, Marco Meglio
At AES 2024, a duo of pediatric epilepsy specialists discussed how implementation science, validated blood biomarkers, and cross-disciplinary collaboration are advancing epilepsy care and closing research gaps. [WATCH TIME: 3 minutes]
By: Isabella Ciccone
The program assembles a collaborative team of in-house and external experts in research, clinical care, and regulatory affairs to navigate gene therapy programs through the drug development process.
By: Isabella Ciccone
With new revisions of the MS diagnostic criteria being made, clinicians highlighted key updates and the broader implications it has for diagnosis, treatment, and healthcare practices worldwide.
By: Marco Meglio, Isabella Ciccone
The investigational therapy was safe, well-tolerated, and showed promising improvements in cognitive measures among patients with dementia with Lewy bodies.
By: Isabella Ciccone, Marco Meglio
Since the Syn-One Test only needs a small punch skin biopsy that can be collected in an office setting, the clinical utility can be enhanced to offer more geographically convenient access for patients earlier in the disease.
By: Marco Meglio, Isabella Ciccone, Emilio Portaccio
The professor of neurology at University of Florence talked about a study presented at ECTRIMS 2024 that validated definitions of progression independent of relapse activity in early relapsing MS. [WATCH TIME: 5 minutes]
By: Isabella Ciccone
As new treatments become available, it may be essential to achieve a timely and accurate diagnosis to enable patients and their family to make informed decisions and retain the greatest level of autonomy.
By: Isabella Ciccone
With new revisions of the MS diagnostic criteria being made, clinicians highlighted key updates and the broader implications it has for diagnosis, treatment, and healthcare practices worldwide.
(833) 317-6278 
